4884.T
Kringle Pharma,Inc.
グロース · 医薬品 · 医薬品 · JP
JPY 415.00
−5.47%Margins
Gross margin
98.9%
EBITDA margin
—
EBIT margin
-1250.7%
Net margin
-1260.3%
FCF margin
—
-97.1%
Return on equity
-46.3%
Return on assets
-96.4%
Return on invested capital
0.04x
Asset turnover
-JPY 755.0M
Cash from operations
JPY 130
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026